Latest Vida Ventures Advisors, LLC Stock Portfolio

Vida Ventures Advisors, LLC Performance:

2024 Q4: -2.45%YTD: 86.5%2023: 22.25%

Performance for 2024 Q4 is -2.45%, and YTD is 86.5%, and 2023 is 22.25%.

About Vida Ventures Advisors, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Vida Ventures Advisors, LLC reported an equity portfolio of $146.3 Millions as of 31 Dec, 2024.

The top stock holdings of Vida Ventures Advisors, LLC are CNTA, , . The fund has invested 45% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 32.5% of portfolio in TECTONIC THERAPEUTICS, INC.

Vida Ventures Advisors, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vida Ventures Advisors, LLC made a return of -2.45% in the last quarter. In trailing 12 months, it's portfolio return was 86.5%.

New Buys

No new stocks were added by Vida Ventures Advisors, LLC

Additions

No additions were made to existing positions by Vida Ventures Advisors, LLC

Reductions

None of the existing positions were reduced by Vida Ventures Advisors, LLC

Sold off

None of the stocks were completely sold off by Vida Ventures Advisors, LLC

Sector Distribution

Vida Ventures Advisors, LLC has about 56% of it's holdings in Healthcare sector.

Sector	%
Healthcare	56
Others	44

Market Cap. Distribution

Vida Ventures Advisors, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
SMALL-CAP	47.6
UNALLOCATED	44
MID-CAP	6.6
MICRO-CAP	1.8

Stocks belong to which Index?

About 9.2% of the stocks held by Vida Ventures Advisors, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	90.8
RUSSELL 2000	9.2

Top 5 Winners (%)		%
CNTA	centessa pharmaceuticals plc	4.8 %

Top 5 Winners ($)		$
CNTA	centessa pharmaceuticals plc	3.0 M

Top 5 Losers (%)		%
DYN	dyne therapeutics, inc.	-34.4 %
ALLO	allogene therapeutics, inc.	-23.9 %
KRON	kronos bio, inc.	-5.0 %

Top 5 Losers ($)		$
DYN	dyne therapeutics, inc.	-5.0 M
ALLO	allogene therapeutics, inc.	-1.2 M
KRON	kronos bio, inc.	-0.1 M

Vida Ventures Advisors, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vida Ventures Advisors, LLC

Vida Ventures Advisors, LLC has 6 stocks in it's portfolio. DYN proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Vida Ventures Advisors, LLC last quarter.

Last Reported on: 21 Jan, 2025

	Ticker	Namesorted descending	% Portfolio	Shares Held	$ Value	Type	% Change
	CNTA	centessa pharmaceuticals plc	45.01	3,931,820	65,858,000	unchanged	0.00
Historical Trend of CENTESSA PHARMACEUTICALS PLC Position Held By Vida Ventures Advisors, LLC What % of Portfolio is CNTA?: Number of CNTA shares held: Change in No. of Shares Held:
		tectonic therapeutics, inc.	32.46	1,028,670	47,493,900	unchanged	0.00

		kyverna therapeutics, inc.	11.56	4,523,920	16,919,500	unchanged	0.00

	DYN	dyne therapeutics, inc.	6.56	407,499	9,600,680	unchanged	0.00

	ALLO	allogene therapeutics, inc.	2.62	1,798,160	3,830,090	unchanged	0.00

	KRON	kronos bio, inc.	1.79	2,765,310	2,627,050	unchanged	0.00